The most dominat pathogenic mechanism in thyroid cancer is the activation of the MAPK and PI3K/Akt pathways caused by BRAFV600E mutation, RAS mutation or RET mutation 46. The gene discussed is AKT1; the disease is thyroid gland carcinoma.